NCT04763499 is a NA clinical trial of freeze dried strawberry powder in Vascular Dilation, sponsored by University of California, Davis.

Who is sponsoring NCT04763499?

NCT04763499 is sponsored by University of California, Davis.

What drugs are being tested in NCT04763499?

Interventions in NCT04763499: freeze dried strawberry powder.

What condition does NCT04763499 study?

NCT04763499 studies Vascular Dilation.

Is NCT04763499 still recruiting?

NCT04763499 is currently terminated. Last updated 11 May 2023.

Last reviewed 2023-05-11 · How we verify

NCT04763499

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men

Terminated NA Last updated 11 May 2023

What this trial tests

NA trial testing freeze dried strawberry powder in Vascular Dilation in 4 participants. Terminated before completion.

Timeline

1 December 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	prevention
Enrollment	4
Start date	1 December 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across United States

Drugs / interventions tested

freeze dried strawberry powder

Conditions studied

Vascular Dilation — all drugs for Vascular Dilation →

Sponsor

University of California, Davis

Who can join

Adults 60 to 80, male only, with Vascular Dilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this proposed trial is to examine the vascular protective effects provided by the daily consumption of 39g of freeze dried strawberry powder (FDSP) for four weeks. The study population will be older men (60-80 years of age).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Vascular Dilation

Currently open trials in the same condition.

NCT05545865 — Chardonnay Marc and Vascular Response · NA · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04763499 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 11 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04763499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing